Detalhe da pesquisa
1.
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Cell;
183(4): 1024-1042.e21, 2020 11 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32991844
2.
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
Nature;
583(7815): 290-295, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32422645
3.
A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness.
Antimicrob Agents Chemother;
68(4): e0127323, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38376227
4.
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys.
Eur J Nucl Med Mol Imaging;
50(3): 667-678, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36305907
5.
Structural and functional analysis of a potent sarbecovirus neutralizing antibody.
bioRxiv;
2020 Apr 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32511354
6.
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
Science;
370(6519): 950-957, 2020 11 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32972994